Results 101 to 110 of about 229,492 (119)

Outcome and Safety of Different Cumulative Doses and Protocols of Intravenous Methylprednisolone in Moderate to Severe and Active Graves’ Ophthalmopathy

Ophthalmologica Indonesiana, 2019
Background: Graves’ ophthalmopathy (GO), also known as Graves’ orbitopathy or thyroid eye disease, has a potential sight-threatening complications. The activity and severity are important determinants in GO and are implications for treatment. Intravenous Glucocorticoid (GC) was associated with significantly greater efficacy and
Amelya Permata Sari, M Sidik, Syntia Nusanti   +2 more
openaire   +1 more source

Association Between Graves' Ophthalmopathy and Smoking

Lancet, The, 1990
A P Weetman
exaly   +2 more sources

Graves' Ophthalmopathy

New England Journal of Medicine, 2010
Rebecca S Bahn
exaly  

Occurrence of Ophthalmopathy After Treatment for Graves' Hyperthyroidism

New England Journal of Medicine, 1992
Henric Blomgren, Göran Wallin, Leif Tallstedt   +2 more
exaly  

Relation Between Therapy for Hyperthyroidism and the Course of Graves' Ophthalmopathy

New England Journal of Medicine, 1998
Fausto Bogazzi, Maria Laura Tanda, Luigi Bartalena   +2 more
exaly  

Randomised Double-Blind Trial of Prednisone Versus Radiotherapy in Graves' Ophthalmopathy

Lancet, The, 1993
M F Prummel, M P Mourits, M F Prummel
exaly  

Teprotumumab for Thyroid-Associated Ophthalmopathy

New England Journal of Medicine, 2017
Mario Salvi, Daniel G Ezra, Alessandro Antonelli   +2 more
exaly  

Prednisone and Cyclosporine in the Treatment of Severe Graves' Ophthalmopathy

New England Journal of Medicine, 1989
Guido Krenning, R van der Gaag, Maarten Mourits   +2 more
exaly  

Pathogenesis of Graves' Ophthalmopathy

New England Journal of Medicine, 1993
Armin E Heufelder, Franklin H Epstein, R S Bahn   +2 more
exaly  

Cyclosporin Improves Graves' Ophthalmopathy.

Lancet, The, 1983
Marian Ludgate, M Ludgate, Alan Michael McGregor   +2 more
exaly